“2-Chloroadenosine-2’,3’-acetonide” has been added to your cart.
“Cabazitaxel” has been added to your cart.
“D-Lactolactoyl-Thr-Octreotide” has been added to your cart.
“Trans-Sobrerol” has been added to your cart.
“Dutasteride” has been added to your cart.
“Ribociclib Chloro Amide Impurity” has been added to your cart.
“4-Fluorobenzoic Acid” has been added to your cart.
-100%


Betamethasone EP Impurity G
ISP CAT No | |
---|---|
CAS No | |
Mol.F. | |
Mol.Wt. | |
Inv. Status |
Disclaimer
The product information provided on this website by ISPStandards is based on the best available understanding at the time of publication. Customers are responsible for verifying the accuracy of this information before making a purchase. ISPStandards may update product details as new information or specifications become available, without prior notice.
- Product Overview
- Description
- Technical Data
Description
Chemical Name: 11α,17,21-Trihydroxy-16β-methylpregna-1,4-diene-3,20-dione
Shipping Temperature:
Ambient
HSN Code:
38229010
Country of Origin: India
Smiles: C[C@@]12[C@](C(CO)=O)(O)[C@@H](C)C[C@@]1([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3([H])[C@H](O)C2)=O
Additional Information
Betamethasone EP Impurity G is chemically 11α,17,21-Trihydroxy-16β-methylpregna-1,4-diene-3,20-dione.
Betamethasone EP Impurity G is supplied with detailed characterization data compliant with regulatory guideline. Betamethasone EP Impurity G can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Betamethasone.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. ISP Standards products are for analytical purpose only and not for human use.
Application of LC–MSn in conjunction with mechanism-based stress studies in the elucidation of drug impurity structure: Rapid identification of a process impurity in betamethasone 17-valerate drug substance